A Multi-center, double-blind, randomized study evaluating de novo weekly and once every 2 week darbepoetin alfa dosing for the correction of anemia in pediatric subjects with chronic kidney disease recieving and not receiving dialysis
ID Number 08-1283Principal Investigator(s)
Department(s) or Division(s)
The purpose of this study is to evaluate if giving darbepoetin alfa once every week or every two weeks to the patient will safely correct his/her anemia (low blood cell count).
Recruiting Patients: Yes